Standex International Corporation
NYSE:SXIIndustrial - Machinery
+$12.56 today
- Market cap
- $2.82B
- Beta
- 1.08
- P/E (TTM)
- 37.5
- EPS (TTM)
- $8.22
- Dividend yield
- 0.43%
Volume 0.11M
Average 0.19M
SXI Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Standex International CorporationNYSE: SXI
Research & Development · Q4 FY2026 · quarter ended Jun 2026
Research & development remains negative
Q4 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2026, unchanged from a year earlier.
- Research & development increased in 1 of the last 3 fiscal years.
- FY2026 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2026
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2026 | 2026-06-30 | 0 | — |
| FY2025 | 2025-06-30 | 0 | -100.0% |
| FY2024 | 2024-06-30 | 20.5M | +19.2% |
| FY2023 | 2023-06-30 | 17.2M | +41.0% |
| FY2022 | 2022-06-30 | 12.2M | — |
Research & Development vs competitors
How SXI compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Research & development amounts to 0.0% of revenue for SXI, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $49.02M USD | +17.0% | +14.7% | 6.1% | |
| LTM Jul 2026 | $16.56M USD | +15.4% | +6.3% | 1.4% | |
| LTM Mar 2026 | $15.74M USD | +37.8% | +20.6% | 5.3% | |
| LTM Jul 2026 | $5.1M USD | — | — | 0.6% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | -100.0% | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | -100.0% | — | 0.0% | |
| LTM Feb 2026 | $0 USD | -100.0% | — | 0.0% | |
| LTM Mar 2026 | CA$0 CAD | — | — | 0.0% | |
| LTM Dec 2025 | $0 USD | — | — | — | |
| Peer median (excluding SXI) | — | -42.3% | +14.7% | 0.0% | |
Competitors are the stored peer set for SXI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 | FY2026 Jun 2026 |
|---|---|---|---|---|---|
| Revenue | 735.34M | 741.05M | 720.64M | 790.11M | 891.6M |
| Cost of Revenue | 465.39M | 455.95M | 438.63M | 489.47M | 519.57M |
| Gross Profit | 269.95M | 285.1M | 282M | 300.64M | 372.03M |
| Gross Margin | 36.7% | 38.5% | 39.1% | 38.1% | 41.7% |
| Research & Development | 12.2M | 17.2M | 20.5M | 0 | 0 |
| Selling, General & Admin | 169.89M | 172.34M | 169.6M | 193.36M | 201.6M |
| Operating Expenses | 181.65M | 114.01M | 180.26M | 178.75M | 178.45M |
| Depreciation & Amortization | 29.7M | 28.47M | 28.14M | 35.44M | 38.65M |
| EBITDA | 129.71M | 141.85M | 123.26M | 128.18M | 232.31M |
| EBITDA Margin | 17.6% | 19.1% | 17.1% | 16.2% | 26.1% |
| Operating Income | 88.29M | 171.09M | 101.74M | 121.89M | 193.58M |
| Operating Margin | 12.0% | 23.1% | 14.1% | 15.4% | 21.7% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 5.87M | 5.41M | 4.54M | 23.93M | 30.71M |
| Other Income / Expenses | (7.01M) | (7.14M) | (6.62M) | (53.08M) | (30.64M) |
| Income Before Tax | 81.29M | 163.95M | 95.12M | 68.81M | 162.94M |
| Pre-Tax Margin | 11.1% | 22.1% | 13.2% | 8.7% | 18.3% |
| Income Tax Expense | 19.81M | 24.8M | 21.53M | 11.08M | 34.25M |
| Net Income | 61.39M | 138.99M | 73.07M | 55.76M | 104.63M |
| Net Margin | 8.3% | 18.8% | 10.1% | 7.1% | 11.7% |
| EPS (Basic) | 5.13 | 11.77 | 6.21 | 4.68 | 8.68 |
| EPS (Diluted) | 5.06 | 11.57 | 6.14 | 4.64 | 8.68 |
| Weighted Avg Shares | 11.97M | 11.81M | 11.76M | 11.93M | 12.04M |
| Weighted Avg Shares (Diluted) | 12.12M | 12.01M | 11.9M | 12.02M | 12.07M |
Standex International Corporation
NYSE:SXI
Intrinsic Alpha fair value
Locked
Current Price
$232.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.